GCN2-Modulator zur Behandlung von Fortgeschrittenen Soliden Tumoren oder Blutkrebs

Details

Veröffentlichungs-Nr.

EP4768029

Anmeldetag

25. Mai 2023

Veröffentlichung

1. Juli 2026

Rechtsraum

EP

IPC

A61K31/506

Abstract

Provided herein are methods of treating advanced solid tumors in a subject in need thereof, for example, when the subject has advanced squamous cell carcinoma of the head and neck, colorectal cancer, non-small cell lung cancer, and transitional cell carcinoma of the bladder. Also provided herein are methods of treating blood cancers, such as acute myeloid leukemia, in a subject in need thereof.

Anmelder

Firma

Hibercell, Inc.

Land

🇺🇸 USA